BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6089495)

  • 1. An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.
    Yamada M; Kondo M; Tanaka M; Okeda R; Hatakeyama S; Fukui T; Tsukagoshi H
    Acta Neuropathol; 1984; 64(1):6-11. PubMed ID: 6089495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Kappas A
    J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    J Med Genet; 1982 Aug; 19(4):271-6. PubMed ID: 7120315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria.
    Lindberg RL; Martini R; Baumgartner M; Erne B; Borg J; Zielasek J; Ricker K; Steck A; Toyka KV; Meyer UA
    J Clin Invest; 1999 Apr; 103(8):1127-34. PubMed ID: 10207164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromyogram and nerve conduction in patients with acute intermittent porphyria.
    Flügel KA; Druschky KF
    J Neurol; 1977 Mar; 214(4):267-79. PubMed ID: 67190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The enzymopathic nature of porphyria].
    Gajdos A
    Nouv Presse Med; 1976 May; 5(22):1417-22. PubMed ID: 778793
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced ferrochelatase activity in fibroblasts from patients with porphyria variegata.
    Viljoen DJ; Cayanis E; Becker DM; Kramer S; Dawson B; Bernstein R
    Am J Hematol; 1979; 6(3):185-90. PubMed ID: 484541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.
    Mustajoki P
    Ann Clin Res; 1976; 8 Suppl 17():133-8. PubMed ID: 1008483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute porphyrias - A neurological perspective.
    Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
    Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsy case of minamata disease (methylmercury poisoning)--pathological viewpoints of peripheral nerves.
    Eto K; Tokunaga H; Nagashima K; Takeuchi T
    Toxicol Pathol; 2002; 30(6):714-22. PubMed ID: 12512873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.
    Strand LJ; Meyer UA; Felsher BF; Redeker AG; Marver HS
    J Clin Invest; 1972 Oct; 51(10):2530-6. PubMed ID: 5056653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria.
    Sassa S; Zalar GL; Poh-Fitzpatrick MB; Anderson KE; Kappas A
    J Clin Invest; 1982 Apr; 69(4):809-15. PubMed ID: 6804493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute peripheral neuropathy due to hereditary coproporphyria.
    Barohn RJ; Sanchez JA; Anderson KE
    Muscle Nerve; 1994 Jul; 17(7):793-9. PubMed ID: 8008008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protoporphyrinaemia and decreased activities of 5-aminolevulinic acid dehydrase and uroporphyrinogen I synthetase in erythrocytes of a Vitamin B6-deficient epileptic boy given valproic acid and carbamazepine.
    Haust HL; Poon HC; Carson R; VanDeWetering C; Peter F
    Clin Biochem; 1989 Jun; 22(3):201-11. PubMed ID: 2500271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.
    Lamon JM; Frykholm BC; Tschudy DP
    J Med Genet; 1979 Apr; 16(2):134-9. PubMed ID: 458830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral nerve changes in porphyric neuropathy: findings in a sural nerve biopsy.
    Anzil AP; Dozić S
    Acta Neuropathol; 1978 May; 42(2):121-6. PubMed ID: 207074
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased leukocyte ferrochelatase activity in erythropoietic protoporphyria.
    Kondo M; Ohe M; Mizuguchi M
    J Dermatol; 1989 Apr; 16(2):116-21. PubMed ID: 2778187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.